Cost per additional responder for ixekizumab and other...

  • Main
  • 2017 / 08
  • Cost per additional responder for ixekizumab and other...
Journal of Medical Economics 2017 / 08

Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis

Al Sawah, Sarah, Foster, Shonda A, Burge, Russel, Amato, David, Schacht, Alexander, Zhu, Baojin, Hartz, Susanne, Leonardi, Craig
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2017.1362413
Date:
August, 2017
File:
PDF, 620 KB
english, 2017
Conversion to is in progress
Conversion to is failed